BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

INSYS Therapeutics 

10220 South 51st Street
Suite 2
Phoenix  Arizona  85044  U.S.A.
Phone: 602-910-2617 Fax: 602-910-2627


SEARCH JOBS










 Company News
INSYS Therapeutics Named Arizona Bioscience Company Of The Year 9/3/2014 10:25:37 AM
INSYS Therapeutics To Present At Morgan Stanley Global Healthcare Conference 2014 8/26/2014 9:22:05 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Glioblastoma Multiforme 8/25/2014 10:48:04 AM
INSYS Therapeutics Submits NDA For Its New Oral Formulation Of Dronabinol 8/12/2014 3:04:15 PM
INSYS Therapeutics To Report Second Quarter 2014 Results 7/30/2014 11:37:48 AM
INSYS Therapeutics Updates Timing Of NDA For Dronabinol Oral Solution 7/8/2014 6:55:41 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Dravet Syndrome, A Rare Form Of Epilepsy 7/2/2014 11:07:53 AM
INSYS Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance 7/1/2014 11:31:15 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Rare Form Of Epilepsy, Lennox-Gastaut Syndrome 6/25/2014 11:29:53 AM
INSYS Therapeutics To Present At 9th Annual JMP Securities Healthcare Conference 6/11/2014 9:33:57 AM
123456